142 related articles for article (PubMed ID: 7632159)
21. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.
Bouffard DY; Laliberté J; Momparler RL
Biochem Pharmacol; 1993 May; 45(9):1857-61. PubMed ID: 8494545
[TBL] [Abstract][Full Text] [Related]
22. 2',3'-Dideoxycytidine phosphorylation by recombinant mouse and human deoxycytidine kinase.
Johansson M; Karlsson A
Adv Exp Med Biol; 1994; 370():711-4. PubMed ID: 7661004
[No Abstract] [Full Text] [Related]
23. Binding of substrates to human deoxycytidine kinase studied with ligand-dependent quenching of enzyme intrinsic fluorescence.
Kierdaszuk B; Rigler R; Eriksson S
Biochemistry; 1993 Jan; 32(2):699-707. PubMed ID: 8422376
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
[TBL] [Abstract][Full Text] [Related]
26. Unusual nucleoside triphosphate donors for nucleoside kinases: 3'-deoxyadenosine-2'-triphosphate and 2'-deoxyadenosine-3'-triphosphate.
Krawiec K; Kierdaszuk B; Kalinichenko EN; Mikhailopulo IA; Shugar D
Acta Biochim Pol; 1998; 45(1):87-94. PubMed ID: 9701500
[TBL] [Abstract][Full Text] [Related]
27. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
28. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
30. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
31. Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs.
Gaubert G; Gosselin G; Boudou V; Imbach JL; Eriksson S; Maury G
Biochimie; 1999 Nov; 81(11):1041-7. PubMed ID: 10575360
[TBL] [Abstract][Full Text] [Related]
32. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
33. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
34. Kinetic mechanism and inhibition of human liver thymidine kinase.
Ellims PH; Van der Weyden MB
Biochim Biophys Acta; 1981 Aug; 660(2):238-42. PubMed ID: 7284401
[TBL] [Abstract][Full Text] [Related]
35. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
[TBL] [Abstract][Full Text] [Related]
36. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
37. Inorganic tripolyphosphate (PPP(i)) as a phosphate donor for human deoxyribonucleoside kinases.
Krawiec K; Kierdaszuk B; Shugar D
Biochem Biophys Res Commun; 2003 Jan; 301(1):192-7. PubMed ID: 12535661
[TBL] [Abstract][Full Text] [Related]
38. Deoxynucleoside kinases encoded by the yaaG and yaaF genes of Bacillus subtilis. Substrate specificity and kinetic analysis of deoxyguanosine kinase with UTP as the preferred phosphate donor.
Andersen RB; Neuhard J
J Biol Chem; 2001 Feb; 276(8):5518-24. PubMed ID: 11078735
[TBL] [Abstract][Full Text] [Related]
39. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
Starnes MC; Cheng YC
J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
[TBL] [Abstract][Full Text] [Related]
40. Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase.
Usova E; Maltseva T; Földesi A; Chattopadhayaya J; Eriksson S
J Mol Biol; 2004 Dec; 344(5):1347-58. PubMed ID: 15561147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]